Deborah Leverette
Psychiatry · Columbia, SCNPI 1073619847
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,350 of the $11,144 with a category attached, or 66.0%. AbbVie accounts for 74.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $8,378 and has fallen 95.0% since, to $417 in 2025. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $56.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Neurocrine Biosciences, Inc.$814
- Jazz Pharmaceuticals Inc.$243
- Alkermes, Inc.$230
- Otsuka America Pharmaceutical, Inc.$209
- Ironshore Pharmaceuticals Inc.$202
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$7,35066%
- Travel & lodging$2292%
- Food & beverage$3,53532%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 71 | $8,259 |
| Neurocrine Biosciences, Inc. | 17 | $814 |
| Jazz Pharmaceuticals Inc. | 4 | $243 |
| Alkermes, Inc. | 9 | $230 |
| Otsuka America Pharmaceutical, Inc. | 13 | $209 |
| Ironshore Pharmaceuticals Inc. | 7 | $202 |
| Axsome Therapeutics, Inc. | 7 | $190 |
| Johnson & Johnson | 7 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $156 |
| Sunovion Pharmaceuticals Inc. | 14 | $152 |
| Bausch Health US, LLC | 8 | $113 |
| Lundbeck LLC | 5 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Almatica Pharma LLC | 3 | $48 |
| Corium, LLC | 4 | $47 |
| Merck | 2 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| Eisai Inc. | 2 | $25 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,144 in reported general payments places this provider in the 90th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 16 | $127,554 |
| VraylarCariprazine Hcl | 54 | $99,830 |
| TrintellixVortioxetine Hydrobromide | 20 | $20,953 |
| RexultiBrexpiprazole | 12 | $17,404 |
| VyvanseLisdexamfetamine Dimesylate | 21 | $7,854 |
| FetzimaLevomilnacipran Hcl | 13 | $7,442 |
| Lurasidone Hcl | 34 | $5,938 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 29 | $4,905 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 112 | $3,004 |
| Ziprasidone Hcl | 24 | $2,672 |
| Bupropion XlBupropion Hcl | 61 | $2,351 |
| Eszopiclone | 27 | $1,969 |
| Vilazodone Hcl | 12 | $1,561 |
| Lamotrigine | 48 | $1,379 |
| Clonazepam | 138 | $1,208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $814 | $127,55416 claims |
| AbbVieVraylar, Fetzima | $8,259 | $107,27267 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $156 | $28,80741 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $209 | $17,40412 claims |
| Almatica Pharma LLCSertraline Hcl | $48 | $44114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Columbia
- Meera NarasimhanColumbia$57K
- Gariane GunterColumbia$46K
- Nioaka CampbellColumbia$11K
- Timothy MaloneColumbia$7K
- Kelly DionColumbia$7K
- Kevin KrebsColumbia$6K
- James RiddleColumbia$6K
- Lauren BarronColumbia$6K
- Robert SchnackenbergColumbia$6K
- Brittany AlbrightMount Pleasant$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.